UK markets open in 1 hour 29 minutes

Novartis AG (0QLR.IL)

IOB - IOB Delayed price. Currency in CHF
Add to watchlist
84.47-0.50 (-0.59%)
At close: 06:10PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
14,850,000
14,850,000
6,955,000
24,021,000
8,072,000
Depreciation & amortisation
8,277,000
8,277,000
6,705,000
5,597,000
6,464,000
Deferred income taxes
551,000
551,000
1,128,000
1,625,000
1,807,000
Stock-based compensation
865,000
865,000
791,000
700,000
738,000
Change in working capital
-369,000
-369,000
-796,000
-73,000
-291,000
Accounts receivable
-1,504,000
-1,504,000
-397,000
-352,000
137,000
Inventory
-546,000
-546,000
-560,000
-102,000
-543,000
Accounts payable
479,000
479,000
-181,000
-111,000
-324,000
Other working capital
11,705,000
11,705,000
11,997,000
12,515,000
11,065,000
Other non-cash items
-785,000
-785,000
-3,000
-209,000
-1,065,000
Net cash provided by operating activities
14,458,000
14,458,000
14,236,000
15,071,000
13,650,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,753,000
-2,753,000
-2,239,000
-2,556,000
-2,585,000
Acquisitions, net
-
-
-
-
-9,964,000
Purchases of investments
-747,000
-747,000
-34,810,000
-16,591,000
-2,130,000
Sales/maturities of investments
11,596,000
11,596,000
39,490,000
2,738,000
1,215,000
Other investing activities
-
-
-1,000
-55,000
-59,000
Net cash used for investing activities
5,596,000
5,596,000
1,468,000
4,208,000
-13,182,000
Cash flows from financing activities
Debt repayment
-2,481,000
-2,481,000
-2,837,000
-5,987,000
-2,315,000
Common stock repurchased
-8,719,000
-8,719,000
-10,652,000
-3,057,000
-2,842,000
Dividends paid
-7,255,000
-7,255,000
-7,506,000
-7,368,000
-6,987,000
Other financing activities
192,000
192,000
-38,000
69,000
-149,000
Net cash used provided by (used for) financing activities
-17,564,000
-17,564,000
-20,681,000
-16,290,000
-2,158,000
Net change in cash
5,876,000
5,876,000
-4,890,000
2,749,000
-1,454,000
Cash at beginning of period
7,517,000
7,517,000
12,407,000
9,658,000
11,112,000
Cash at end of period
13,393,000
13,393,000
7,517,000
12,407,000
9,658,000
Free cash flow
Operating cash flow
14,458,000
14,458,000
14,236,000
15,071,000
13,650,000
Capital expenditure
-2,753,000
-2,753,000
-2,239,000
-2,556,000
-2,585,000
Free cash flow
11,705,000
11,705,000
11,997,000
12,515,000
11,065,000